Skin tone and glow improvement may be seen after several weeks of consistent use
Clinical data shows these symptoms disrupt 40-70% of patients[link_1], sometimes reaching 85% of cases
This distinction is particularly relevant for clinical practice, as REWIND demonstrated benefits in patients at moderate cardiovascular risk without previous events
At Josie, we recommend tapering off gradually, which means lowering your dose to get your body ready to get off your GLP-1 medication
These can be taken in the evening to control nocturnal acid secretion without affecting morning Rybelsus absorption, provided the timing guidelines are followed
Its proven for weight and blood sugar, though so far only approved for weight loss, with a diabetes filing expected later in 2026